000739:SHE
Apeloa Pharmaceutical Co Ltd
CNÂ¥23.42
arrow_downward
-1.64%(-0.39) 1D
Oct 16, 3:04:48 PM GMT+8 · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 000739...
Open
CNÂ¥24.04
High
CNÂ¥24.76
Low
CNÂ¥23.09
Mkt. cap
28.68B
Avg. vol.
16.27M
Volume
15.09M
Dividend
1.61%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
Oct 8, 2026
P/E ratio
31.78
52-wk high
CNÂ¥28.50
52-wk low
CNÂ¥14.89
EPS
CNÂ¥0.74
Shares outstanding
1.16B
No. of employees
7K
Open
CNÂ¥24.04
High
CNÂ¥24.76
Low
CNÂ¥23.09
Mkt. cap
28.68B
Avg. vol.
16.27M
Volume
15.09M
Dividend
1.61%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
Oct 8, 2026
P/E ratio
31.78
52-wk high
CNÂ¥28.50
52-wk low
CNÂ¥14.89
EPS
CNÂ¥0.74
Shares outstanding
1.16B
No. of employees
7K
News stories
From web sources and news partners
marketscreener.com
·
40 minutes ago
Nasdaq Falls to End Four-Week Winning Streak Amid Tech Sell-Off
Finimize
·
46 minutes ago
S&P 500’S Tech Slump Put AI Debt In Focus
The Motley Fool
·
48 minutes ago
Inflation Rose to 3.7% in September. Is It Time to Sell the S&P 500?
Profile
Apeloa Pharmaceutical Co., Ltd., known as Apeloa, is a Chinese pharmaceutical manufacturer under Hengdian Group. The company is headquartered in Hengdian, Dongyang, Zhejiang, China. It was founded in 1989 and has been listed on the Shenzhen Stock Exchange since 9 May 1997. Apeloa provides contract development and manufacturing services and manufactures APIs and finished dosage forms; products span cardiovascular, anti-infective, psychiatric and oncology areas.
Apeloa has 7400 employees, 8 manufacturing sites and 3 R&D centers in Boston, Shanghai and Hengdian, covering flow chemistry, synthetic biology and biocatalysis, and peptide development. It has invested over USD20 million in flow chemistry over the past ten years in an effort to advance sustainable pharmaceutical manufacturing. In Boston, its 17,000-square-foot facility does R&D related to chemistry needs in drug development, including preclinical chemistry, scale-up production and new drug development.
Apeloa Pharmaceutical has successfully passed 20 U.S. FDA inspections since 2006. Wikipedia
About Apeloa Pharmaceutical Co Ltd